The effectiveness of Pennsylvania’s share — over $1 billion — of a multi-state settlement with corporations responsible for the opioid crisis is hindered by the commonwealth’s prohibition on a proven strategy that not only keeps drug users safe but raises the likelihood of recovery.

The state legislature should quickly pass a bill, just approved by the House Judiciary Committee, that would decriminalize possession of syringes for illicit drug use. Until then, syringe service programs (SSPs) cannot receive funding from the opioid settlement.

SSPs are legal only in Philadelphia and Pittsburgh, which means that most organizations that provide this service in a competent way — as part of a continuum of care for people with opioid use disorder (OUD) — are considered ineligible for the opioid settlement funding. Allowing these uses will ensure the funds fulfill their purpose: saving as many lives as possible, and getting as many people as possible on the road to recovery.

Some Republican members of the legislature oppose, for serious and understandable reasons, bringing syringe services — also known as needle exchanges — out of the shadows. But a sober explanation of how opioid addiction works, and how well-run SSPs can be part of a system oriented toward recovery, should ensure enough bipartisan support to propel the measure through both chambers and to Gov. Josh Shapiro’s desk.

Advertise with us

Road to recovery

In fact, one of the leading harm reduction advocates in Harrisburg is a Republican. Rep. Jim Struzzi of Indiana County lost his brother to an opioid overdose — but still wasn’t convinced of harm reduction strategies until he visited Prevention Point Pittsburgh, which provides syringe services as part of its care for people with OUD. There, he said, he saw first-hand that the purpose of SSPs is “to get people into recovery” and “to give people hope.”

Besides offering clean needles to remove the danger of communicable diseases like HIV/AIDS and Hepatitis C, syringe service centers provide a place to form relationships with care professionals and a touchpoint to the more extensive systems of care needed for long-term recovery. An SSP provides a safe and convenient place for a person with OUD to be offered access to mental health care, or to be connected by a trusted person to a physician who can prescribe medication, such as buprenorphine or methadone, to treat their addiction.

This is why, according to studies collected by the Centers for Disease Control and Prevention, SSPs have been shown not just to prevent the spread of disease, but to significantly increase the likelihood of recovery. When operated well, they aren’t about making people with OUD permanently comfortable with their condition, as some people argue. They’re about being the first step to getting better.

See no evil

Another Republican, Paul Schemel of Franklin County, has acknowledged that “the data may support that [SSPs] do a net good.” But he believes he “would be enabling an evil to achieve that good,” and that is forbidden.

Mr. Schemel’s moral intuition is correct: One cannot do something evil in pursuit of something good. That’s why one can’t torture a suspect even to try to discover the location of a hidden bomb, or why one can’t intentionally fire missiles at civilians even to save even more civilians.

Advertise with us

But he assumes that providing clean syringes “enables evil.” If SSPs distributed the devices willy-nilly, including to people who don’t currently use drugs, that might be the case. But the context of addiction changes everything.

It is important to understand that for a person in the throes of OUD, injecting opioids is not about chasing euphoria: It’s about avoiding the pure and sometimes deadly horror of withdrawal. In that state, using again is almost completely inevitable. The only question is whether the person uses safely, or uses recklessly.

SSPs don’t encourage people to use opioids who weren’t going to do so anyways. They provide a bare minimum of safety — a sterile needle — to ensure the harm their clients are doing to themselves is limited to the drugs, and not compounded by an infectious disease.

Blood money

A skeptic might reply that, since they are based on the assumption that people with OUD will keep using no matter what, syringe services communicate hopelessness, when what people suffering with addiction need is to be told that they, and only they, have the power to liberate themselves.

It is true that recovery only sticks when a person decides for himself or herself that it’s time. But the evidence is clear that people with OUD are much, much more likely to do that when they have a community of support and a continuum of care — including, crucially, medication for OUD. SSPs can be a touchpoint for both of these, and in fact one of the most effective touchpoints. There is more hope there than alone, or among fellow sufferers, sharing needles on the streets.

Advertise with us

This has been shown in practice time and again, such as at the FAVOR recovery site and community center in Bolivar, reported on by the investigative agency SpotlightPA. But FAVOR lost $150,000 in Westmoreland County funding when its executive director publicized its syringe program: Because the state considers the devices “drug paraphernalia,” the county didn’t want to incur liability by funding them. So a point of hope in rural Pennsylvania was dimmed.

Organizations like FAVOR are exactly what state and county opioid settlement money should be funding. When they are excluded, that money doesn’t go as far as it could — and people suffer and die who didn’t need to.

The deadlines for spending the settlement money are fast approaching — the end of December, at the latest. Decriminalizing syringe services is essential to making that blood money serve the communities that opioid companies so devastated.